Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc. (XAGE)

Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Market Cap

$3.3M

Revenue

$50K

P/E Ratio

N/A

P/B Ratio

-37.13

D/E Ratio

-0.14

Dividend Yield

0.00%

Updated: June 5 at 05:49:40